CCL20 and myeloid sarcoma: Furthermore, concentrations of CXCL8, CXCL10 and CCL20 in sera did not significantly differ among subgroups of MS patients divided by presence or localization of demyelinating lesions (supratentorial, infratentorial and cervical), sex, or history of optic neuritis.